Market Size of Global Transplantation Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 9.90 % |
Fastest Growing Market | North America |
Largest Market | Asia-Pacific |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Transplantation Market Analysis
The Transplantation Market is expected to register a CAGR of 9.9% during the forecast period (2022-2027).
A major factor driving market growth is the rising demand for novel tissue transplantation products and organ transplantation to treat organ failure. According to the study published in Current Transplantation Reports, titled 'Diagnostic Testing of COVID-19 in Solid Organ Transplantation: Current Clinical Application and Future Strategies' in October 2020, multiple elements of solid organ transplantation have been impacted by the COVID-19 pandemic, including donor and recipient appropriateness, as well as infection and transmission prevention following transplantation. Moreover, according to the study titled "Epidemiology of Organ Failure Before and During COVID-19 Pandemic Surge Conditions," published in the American Journal of Critical Care in May 2022, during the pandemic, renal failure was the most common type of organ failure at admission and respiratory failure was the most common type of hospital-onset organ failure. The SARS-CoV-2-positive group showed a 231% increase in respiratory failure compared with the pre-pandemic group. Thus, with increasing organ failure, the demand for transplantation increases over the forecast period.
Moreover, the global demand for tissue and organ transplantation, particularly kidney, heart, liver, and lung transplantation, is extremely high. Organ failure is caused by a variety of factors, including poor dietary habits, excessive alcohol consumption, a lack of exercise, and drug abuse. As a result, transplantation product demand is expected to increase shortly. The rising donation of organs is one of the biggest contributors to the growth of the market studied. According to the data published by the Association of Organ Procurement Organizations (AOPO) in January 2021, more than 12,500 people donated one or more organs in 2020, up 6% from the previous year. The number of organs donated from dead donors increased to over 36,500 in 2020, an increase of almost 2% year over year. For the seventh year in a running, these retrieved organs saved more than 33,000 lives, exceeding the previous year's totals. There were also notable increases in Donation after Circulatory Death (DCD) contributions, which totaled more than 3,000 donors, up 18% year over year.
Furthermore, rising in the prevalence of chronic diseases such as cancer and heart and kidney diseases is propelling the growth of the market. For Instance, in March 2020, as per data released on World Kidney Day, a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF), kidney disease affected around 850 million people globally. In addition, as per the Globocan 2020 report published by Global Cancer Observatory, which estimated the incidence and mortality of 36 cancer in 185 countries globally, there were an estimated 19,292,789 new cases of cancer diagnosed in 2020, and about 9,958,133 people died due to cancer.
Additionally, product launches by the key market players, as well as various strategies adopted by the market players such as mergers and acquisitions, are anticipated to boost the market over the forecast period. For Instance, in June 2021, transplant diagnostics company CareDx acquired New York-based Transplant Hero, the developer of a smartphone app that's aimed at supporting the needs of transplant patients. As a result of such initiatives by key market players, the transplantation product becomes more accessible, boosting the market growth.
Thus, all aforementioned factors are anticipated to boost the market over the forecast period. However, the shortage of organ donors and ethical and cultural issues restraint the market over the forecast period,
Transplantation Industry Segmentation
As per the scope of the report, organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. The Global Transplantation Market is Segmented by Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), Application (Organ Transplantation, Tissue Transplantation), End-Use (Hospitals, Transplant Centers, Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
By Product | |
Tissue Products | |
Immunosuppressive Drugs | |
Preservation Solution |
By Application | |
Organ Transplantation | |
Tissue Transplantation |
By End Use | |
Hospitals | |
Transplant Centers | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Transplantation Market Size Summary
The transplantation market is poised for significant growth, driven by the increasing demand for tissue and organ transplantation to address organ failure. Factors such as poor dietary habits, excessive alcohol consumption, and drug abuse have contributed to a rise in organ failure, thereby boosting the need for transplantation products. The market is further supported by the growing prevalence of chronic diseases like cancer and kidney diseases, which necessitate transplant procedures. The COVID-19 pandemic has also influenced the market dynamics, with a notable increase in organ failure cases, particularly respiratory and renal failures, which has heightened the demand for transplants. The market is characterized by advancements in transplantation technology and the introduction of new products, which are expected to propel the number of transplant procedures, including those for kidneys, liver, heart, lungs, and tissues.
North America is anticipated to maintain a dominant position in the transplantation market, supported by well-funded organizations and government initiatives that promote organ transplantation. The region's infrastructure and awareness campaigns have led to a significant number of organ donations and transplantations, driving market growth. The demand for solid organ transplants, particularly kidneys and livers, is on the rise, further fueling the market expansion. The market landscape is highly fragmented, with numerous players engaging in mergers, acquisitions, and product launches to enhance their market presence. Key industry players such as Abbvie, Inc., Arthrex, Inc., Zimmer Biomet, Medtronic, Novartis AG, and Strykers are actively contributing to the market's growth through strategic initiatives and innovative product offerings.
Global Transplantation Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Burden of Chronic Diseases
-
1.2.2 Increasing Burden of Organ Failure
-
1.2.3 Technological Advancement in Transplantation Method
-
-
1.3 Market Restraints
-
1.3.1 Shortage of Organ Donors
-
1.3.2 Ethical and Cultural Issues
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product
-
2.1.1 Tissue Products
-
2.1.2 Immunosuppressive Drugs
-
2.1.3 Preservation Solution
-
-
2.2 By Application
-
2.2.1 Organ Transplantation
-
2.2.2 Tissue Transplantation
-
-
2.3 By End Use
-
2.3.1 Hospitals
-
2.3.2 Transplant Centers
-
2.3.3 Others
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle-East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Global Transplantation Market Size FAQs
What is the current Global Transplantation Market size?
The Global Transplantation Market is projected to register a CAGR of 9.90% during the forecast period (2024-2029)
Who are the key players in Global Transplantation Market?
Zimmer Biomet, Novartis AG, 21st Century Medicine, Arthrex, Inc. and Strykers are the major companies operating in the Global Transplantation Market.